4//SEC Filing
Srivastava Deepak 4
Accession 0001209191-22-060596
CIK 0001858848other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 7:59 PM ET
Size
5.8 KB
Accession
0001209191-22-060596
Insider Transaction Report
Form 4
Srivastava Deepak
Director
Transactions
- Purchase
Common Stock
2022-11-21$2.60/sh+230,769$599,999→ 372,435 total(indirect: See Footnote)
Holdings
- 191,666
Common Stock
Footnotes (1)
- [F1]These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.
Documents
Issuer
Tenaya Therapeutics, Inc.
CIK 0001858848
Entity typeother
Related Parties
1- filerCIK 0001868501
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 7:59 PM ET
- Size
- 5.8 KB